Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.930 | 2.60e-15 | 2.77e-03 | 4.34e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
ACO2 | 50 | 50 | 1.000 | 1.076 | 191 | Yes | - |
RSL24D1 | 51187 | 36 | 1.300 | 1.020 | 59 | Yes | - |
[ PA2G4 ] | 5036 | 1 | -0.272 | 0.930 | 61 | - | Yes |
EIF6 | 3692 | 14 | 0.700 | 1.013 | 267 | Yes | - |
RPS11 | 6205 | 36 | 0.993 | 1.113 | 175 | Yes | - |
RPL14 | 9045 | 42 | 1.250 | 1.113 | 143 | Yes | - |
RPL8 | 6132 | 9 | 0.778 | 0.967 | 218 | Yes | - |
PSMB2 | 5690 | 18 | 0.877 | 1.026 | 117 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
HSPD1 | 3329 | 35 | 0.913 | 1.035 | 286 | Yes | - |
PGD | 5226 | 75 | 1.201 | 1.106 | 138 | Yes | - |
RPL11 | 6135 | 9 | 0.718 | 1.017 | 200 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
EIF6 | 3692 | PA2G4 | 5036 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
HSPD1 | 3329 | EIF6 | 3692 | pp | -- | int.I2D: BioGrid_Yeast |
EIF6 | 3692 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPL8 | 6132 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
RPL11 | 6135 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
PA2G4 | 5036 | RPL11 | 6135 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, IntAct |
EIF6 | 3692 | RSL24D1 | 51187 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
PSMB2 | 5690 | RPL8 | 6132 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
EIF6 | 3692 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PA2G4 | 5036 | RPL8 | 6132 | pp | -- | int.Intact: MI:0914(association); int.I2D: BCI, IntAct |
ACO2 | 50 | EIF6 | 3692 | pp | -- | int.I2D: YeastLow |
RPL11 | 6135 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
RPL8 | 6132 | RPL11 | 6135 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium, IntAct_Yeast |
RPL8 | 6132 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPL14 | 9045 | pp | -- | int.I2D: BioGrid_Yeast |
ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
ACO2 | 50 | HSPD1 | 3329 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RPL11 | 6135 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006413 | translational initiation | 4.31e-08 | 6.21e-04 | 5.520 | 5 | 17 | 131 |
GO:0042273 | ribosomal large subunit biogenesis | 1.25e-07 | 1.81e-03 | 8.116 | 3 | 4 | 13 |
GO:0019083 | viral transcription | 4.42e-07 | 6.37e-03 | 5.891 | 4 | 10 | 81 |
GO:0006415 | translational termination | 5.89e-07 | 8.50e-03 | 5.788 | 4 | 10 | 87 |
GO:0016071 | mRNA metabolic process | 6.13e-07 | 8.84e-03 | 4.752 | 5 | 31 | 223 |
GO:0006414 | translational elongation | 7.71e-07 | 1.11e-02 | 5.692 | 4 | 13 | 93 |
GO:0016070 | RNA metabolic process | 1.02e-06 | 1.46e-02 | 4.605 | 5 | 32 | 247 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.21e-06 | 1.74e-02 | 5.531 | 4 | 10 | 104 |
GO:0019843 | rRNA binding | 1.27e-06 | 1.84e-02 | 7.061 | 3 | 3 | 27 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.75e-06 | 2.52e-02 | 5.398 | 4 | 11 | 114 |
GO:0019058 | viral life cycle | 1.81e-06 | 2.61e-02 | 5.386 | 4 | 13 | 115 |
GO:0016032 | viral process | 1.91e-06 | 2.76e-02 | 3.755 | 6 | 55 | 534 |
GO:0003735 | structural constituent of ribosome | 3.64e-06 | 5.24e-02 | 5.133 | 4 | 10 | 137 |
GO:0022625 | cytosolic large ribosomal subunit | 7.93e-06 | 1.14e-01 | 6.201 | 3 | 6 | 49 |
GO:0016020 | membrane | 1.08e-05 | 1.55e-01 | 2.516 | 8 | 90 | 1681 |
GO:0070062 | extracellular vesicular exosome | 1.31e-05 | 1.89e-01 | 2.172 | 9 | 104 | 2400 |
GO:0044267 | cellular protein metabolic process | 2.46e-05 | 3.54e-01 | 3.664 | 5 | 29 | 474 |
GO:0006412 | translation | 2.82e-05 | 4.07e-01 | 4.386 | 4 | 20 | 230 |
GO:0006364 | rRNA processing | 5.65e-05 | 8.15e-01 | 5.261 | 3 | 6 | 94 |
GO:0044822 | poly(A) RNA binding | 9.55e-05 | 1.00e+00 | 2.772 | 6 | 49 | 1056 |
GO:0010467 | gene expression | 1.28e-04 | 1.00e+00 | 3.167 | 5 | 59 | 669 |
GO:0005829 | cytosol | 2.03e-04 | 1.00e+00 | 1.946 | 8 | 132 | 2496 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0000054 | ribosomal subunit export from nucleus | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 1 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 2 | 2 |
GO:0003994 | aconitate hydratase activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 2 |
GO:0003723 | RNA binding | 2.48e-03 | 1.00e+00 | 3.398 | 3 | 20 | 342 |
GO:0006458 | 'de novo' protein folding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 2 | 3 |
GO:0030135 | coated vesicle | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 3 |
GO:0005925 | focal adhesion | 3.01e-03 | 1.00e+00 | 3.300 | 3 | 19 | 366 |
GO:0030529 | ribonucleoprotein complex | 3.75e-03 | 1.00e+00 | 4.424 | 2 | 8 | 112 |
GO:0042256 | mature ribosome assembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0005638 | lamin filament | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0043023 | ribosomal large subunit binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 6 |
GO:0030957 | Tat protein binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 3 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0006101 | citrate metabolic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 6 |
GO:0070688 | MLL5-L complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 8 |
GO:0005730 | nucleolus | 7.54e-03 | 1.00e+00 | 1.873 | 5 | 69 | 1641 |
GO:0006098 | pentose-phosphate shunt | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 4 | 10 |
GO:0043032 | positive regulation of macrophage activation | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 10 |
GO:0032727 | positive regulation of interferon-alpha production | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 11 |
GO:0001530 | lipopolysaccharide binding | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 3 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 4 | 14 |
GO:0042026 | protein refolding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 15 |
GO:0050998 | nitric-oxide synthase binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 16 |
GO:0010243 | response to organonitrogen compound | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 3 | 17 |
GO:0050870 | positive regulation of T cell activation | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 17 |
GO:0005759 | mitochondrial matrix | 1.48e-02 | 1.00e+00 | 3.398 | 2 | 14 | 228 |
GO:0005839 | proteasome core complex | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 8 | 18 |
GO:0032733 | positive regulation of interleukin-10 production | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 1 | 19 |
GO:0004298 | threonine-type endopeptidase activity | 1.57e-02 | 1.00e+00 | 5.983 | 1 | 8 | 19 |
GO:0042100 | B cell proliferation | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 21 |
GO:0030863 | cortical cytoskeleton | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 4 | 23 |
GO:0042113 | B cell activation | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 25 |
GO:0043022 | ribosome binding | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 3 | 27 |
GO:0050661 | NADP binding | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 4 | 27 |
GO:0006099 | tricarboxylic acid cycle | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 28 |
GO:0034504 | protein localization to nucleus | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 28 |
GO:0043234 | protein complex | 2.40e-02 | 1.00e+00 | 3.027 | 2 | 18 | 295 |
GO:0042254 | ribosome biogenesis | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 30 |
GO:0001895 | retina homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 34 |
GO:0006605 | protein targeting | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 2 | 35 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 3 | 35 |
GO:0034332 | adherens junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 1 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.04e-02 | 1.00e+00 | 5.022 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 3.12e-02 | 1.00e+00 | 4.983 | 1 | 2 | 38 |
GO:0032729 | positive regulation of interferon-gamma production | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 2 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 4 | 39 |
GO:0042110 | T cell activation | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 3 | 42 |
GO:0014070 | response to organic cyclic compound | 3.52e-02 | 1.00e+00 | 4.805 | 1 | 4 | 43 |
GO:0021762 | substantia nigra development | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 2 | 44 |
GO:0003743 | translation initiation factor activity | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 8 | 49 |
GO:0006091 | generation of precursor metabolites and energy | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 3 | 50 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 17 | 50 |
GO:0006986 | response to unfolded protein | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 50 |
GO:0005905 | coated pit | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 4.24e-02 | 1.00e+00 | 4.531 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 4.40e-02 | 1.00e+00 | 4.476 | 1 | 2 | 54 |
GO:0002039 | p53 binding | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 7 | 55 |
GO:0043066 | negative regulation of apoptotic process | 4.68e-02 | 1.00e+00 | 2.503 | 2 | 31 | 424 |
GO:0005840 | ribosome | 4.72e-02 | 1.00e+00 | 4.373 | 1 | 1 | 58 |
GO:0000502 | proteasome complex | 4.72e-02 | 1.00e+00 | 4.373 | 1 | 17 | 58 |
GO:0051087 | chaperone binding | 4.80e-02 | 1.00e+00 | 4.348 | 1 | 6 | 59 |
GO:0030141 | secretory granule | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 62 |
GO:0006417 | regulation of translation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 1 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 22 | 65 |
GO:0034329 | cell junction assembly | 5.52e-02 | 1.00e+00 | 4.144 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 5.52e-02 | 1.00e+00 | 4.144 | 1 | 5 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 20 | 75 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 6.22e-02 | 1.00e+00 | 3.964 | 1 | 7 | 77 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.38e-02 | 1.00e+00 | 3.927 | 1 | 23 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 3 | 80 |
GO:0050821 | protein stabilization | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 2 | 88 |
GO:0006928 | cellular component movement | 7.32e-02 | 1.00e+00 | 3.723 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 7.32e-02 | 1.00e+00 | 3.723 | 1 | 8 | 91 |
GO:0044281 | small molecule metabolic process | 7.33e-02 | 1.00e+00 | 1.574 | 3 | 58 | 1211 |
GO:0005515 | protein binding | 7.35e-02 | 1.00e+00 | 0.675 | 8 | 184 | 6024 |
GO:0001649 | osteoblast differentiation | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 21 | 92 |
GO:0051082 | unfolded protein binding | 7.47e-02 | 1.00e+00 | 3.692 | 1 | 5 | 93 |
GO:0014069 | postsynaptic density | 8.40e-02 | 1.00e+00 | 3.517 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 8.40e-02 | 1.00e+00 | 3.517 | 1 | 4 | 105 |
GO:0072562 | blood microparticle | 8.86e-02 | 1.00e+00 | 3.437 | 1 | 3 | 111 |
GO:0000209 | protein polyubiquitination | 9.24e-02 | 1.00e+00 | 3.373 | 1 | 20 | 116 |
GO:0044237 | cellular metabolic process | 9.32e-02 | 1.00e+00 | 3.361 | 1 | 5 | 117 |
GO:0006325 | chromatin organization | 9.39e-02 | 1.00e+00 | 3.348 | 1 | 5 | 118 |
GO:0007050 | cell cycle arrest | 9.85e-02 | 1.00e+00 | 3.277 | 1 | 9 | 124 |
GO:0000790 | nuclear chromatin | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 9 | 129 |
GO:0016887 | ATPase activity | 1.10e-01 | 1.00e+00 | 3.102 | 1 | 7 | 140 |
GO:0006457 | protein folding | 1.13e-01 | 1.00e+00 | 3.071 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 1.14e-01 | 1.00e+00 | 3.051 | 1 | 7 | 145 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.17e-01 | 1.00e+00 | 3.012 | 1 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 1.18e-01 | 1.00e+00 | 3.002 | 1 | 24 | 150 |
GO:0005769 | early endosome | 1.19e-01 | 1.00e+00 | 2.983 | 1 | 2 | 152 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 7 | 165 |
GO:0030424 | axon | 1.30e-01 | 1.00e+00 | 2.856 | 1 | 4 | 166 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.33e-01 | 1.00e+00 | 2.813 | 1 | 20 | 171 |
GO:0031625 | ubiquitin protein ligase binding | 1.38e-01 | 1.00e+00 | 2.755 | 1 | 14 | 178 |
GO:0005737 | cytoplasm | 1.81e-01 | 1.00e+00 | 0.674 | 5 | 110 | 3767 |
GO:0005615 | extracellular space | 1.87e-01 | 1.00e+00 | 1.329 | 2 | 17 | 957 |
GO:0005975 | carbohydrate metabolic process | 1.91e-01 | 1.00e+00 | 2.248 | 1 | 9 | 253 |
GO:0005739 | mitochondrion | 2.00e-01 | 1.00e+00 | 1.268 | 2 | 28 | 998 |
GO:0043065 | positive regulation of apoptotic process | 2.02e-01 | 1.00e+00 | 2.165 | 1 | 10 | 268 |
GO:0005743 | mitochondrial inner membrane | 2.08e-01 | 1.00e+00 | 2.117 | 1 | 8 | 277 |
GO:0005856 | cytoskeleton | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 12 | 291 |
GO:0006200 | ATP catabolic process | 2.18e-01 | 1.00e+00 | 2.041 | 1 | 15 | 292 |
GO:0005654 | nucleoplasm | 2.26e-01 | 1.00e+00 | 1.152 | 2 | 76 | 1082 |
GO:0019901 | protein kinase binding | 2.34e-01 | 1.00e+00 | 1.923 | 1 | 21 | 317 |
GO:0007411 | axon guidance | 2.35e-01 | 1.00e+00 | 1.914 | 1 | 13 | 319 |
GO:0008283 | cell proliferation | 2.41e-01 | 1.00e+00 | 1.874 | 1 | 14 | 328 |
GO:0000278 | mitotic cell cycle | 2.81e-01 | 1.00e+00 | 1.620 | 1 | 48 | 391 |
GO:0009986 | cell surface | 2.88e-01 | 1.00e+00 | 1.580 | 1 | 11 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.94e-01 | 1.00e+00 | 1.541 | 1 | 15 | 413 |
GO:0005524 | ATP binding | 2.95e-01 | 1.00e+00 | 0.889 | 2 | 60 | 1298 |
GO:0055114 | oxidation-reduction process | 2.99e-01 | 1.00e+00 | 1.517 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 3.19e-01 | 1.00e+00 | 1.401 | 1 | 18 | 455 |
GO:0005634 | nucleus | 3.20e-01 | 1.00e+00 | 0.399 | 5 | 136 | 4559 |
GO:0006915 | apoptotic process | 3.76e-01 | 1.00e+00 | 1.115 | 1 | 33 | 555 |
GO:0045087 | innate immune response | 3.97e-01 | 1.00e+00 | 1.012 | 1 | 24 | 596 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.49e-01 | 1.00e+00 | 0.782 | 1 | 11 | 699 |
GO:0003677 | DNA binding | 6.53e-01 | 1.00e+00 | -0.019 | 1 | 28 | 1218 |
GO:0006351 | transcription, DNA-templated | 7.19e-01 | 1.00e+00 | -0.267 | 1 | 31 | 1446 |
GO:0005886 | plasma membrane | 9.06e-01 | 1.00e+00 | -1.103 | 1 | 45 | 2582 |